Patent ID: 11938181
Assignee: NFERENCE, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 0:
1. A method for reducing the risk of a subject acquiring or fully presenting a disease case by SARS-CoV-2 infection, comprising:
determining a plurality of demographic covariates of the subject, wherein
determining the plurality of demographic covariates comprises:
determining a propensity score for the subject; and
generating at least a negative cohort as a function of the propensity score;

identifying one or more vaccines not administered to the subject within the past 1 year, the one or more vaccines not having been administered to the subject within the past 1 year selected from a group comprising a haemophilus influenzae type B (Hib) vaccine, an influenza vaccine, a diphtheria-pertussis-tetanus vaccine, and a measles-mumps-rubella vaccine using a logistic regression model as a function of the plurality of demographic covariates of the subject and the propensity score; and
administering to the subject at least one of the one or more vaccines identified as not having been administered to the subject within the past 1 year.